Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 86
Filtrar
1.
AAPS PharmSciTech ; 25(5): 106, 2024 May 09.
Artículo en Inglés | MEDLINE | ID: mdl-38724834

RESUMEN

The primary factor underlying the virulence of Candida albicans is its capacity to form biofilms, which in turn leads to recurrent complications. Over-the-counter antifungal treatments have proven ineffective in eliminating fungal biofilms and the inflammatory cytokines produced during fungal infections. Chitosan nanoparticles offer broad and versatile therapeutic potential as both antifungal agents and carriers for antifungal drugs to combat biofilm-associated Candida infections. In our study, we endeavoured to develop chitosan nanoparticles utilising chitosan and the antifungal crosslinker phytic acid targeting C. albicans. Phytic acid, known for its potent antifungal and anti-inflammatory properties, efficiently crosslinks with chitosan. The nanoparticles were synthesised using the ionic gelation technique and subjected to analyses including Fourier transform infrared spectroscopy, dynamic light scattering, and zeta potential analysis. The synthesised nanoparticles exhibited dimensions with a diameter (Dh) of 103 ± 3.9 nm, polydispersity index (PDI) of 0.33, and zeta potential (ZP) of 37 ± 2.5 mV. These nanoparticles demonstrated an antifungal effect with a minimum inhibitory concentration (MIC) of 140 ± 2.2 µg/mL, maintaining cell viability at approximately 90% of the MIC value and reducing cytokine levels. Additionally, the nanoparticles reduced ergosterol content and exhibited a 62% ± 1.2 reduction in biofilm susceptibility, as supported by colony-forming unit (CFU) and XTT assays-furthermore, treatment with nanoparticles reduced exopolysaccharide production and decreased secretion of aspartyl protease by C. albicans. Our findings suggest that the synthesised nanoparticles effectively combat Candida albicans infections. In vivo studies conducted on a mouse model of vaginal candidiasis confirmed the efficacy of the nanoparticles in combating fungal infections in vivo.


Asunto(s)
Antifúngicos , Biopelículas , Candida albicans , Quitosano , Pruebas de Sensibilidad Microbiana , Nanopartículas , Ácido Fítico , Quitosano/química , Biopelículas/efectos de los fármacos , Nanopartículas/química , Antifúngicos/farmacología , Antifúngicos/administración & dosificación , Animales , Candida albicans/efectos de los fármacos , Ratones , Pruebas de Sensibilidad Microbiana/métodos , Ácido Fítico/farmacología , Ácido Fítico/administración & dosificación , Ácido Fítico/química , Femenino , Candidiasis/tratamiento farmacológico , Tamaño de la Partícula , Portadores de Fármacos/química , Reactivos de Enlaces Cruzados/química , Citocinas/metabolismo
2.
AAPS PharmSciTech ; 25(4): 85, 2024 Apr 11.
Artículo en Inglés | MEDLINE | ID: mdl-38605158

RESUMEN

Cervical cancer (CC) is the fourth leading cancer type in females globally. Being an ailment of the birth canal, primitive treatment strategies, including surgery, radiation, or laser therapy, bring along the risk of infertility, neonate mortality, premature parturition, etc. Systemic chemotherapy led to systemic toxicity. Therefore, delivering a smaller cargo of therapeutics to the local site is more beneficial in terms of efficacy as well as safety. Due to the regeneration of cervicovaginal mucus, conventional dosage forms come with the limitations of leaking, the requirement of repeated administration, and compromised vaginal retention. Therefore, these days novel strategies are being investigated with the ability to combat the limitations of conventional formulations. Novel carriers can be engineered to manipulate bioadhesive properties and sustained release patterns can be obtained thus leading to the maintenance of actives at therapeutic level locally for a longer period. Other than the purpose of CC treatment, these delivery systems also have been designed as postoperative care where a certain dose of antitumor agent will be maintained in the cervix postsurgical removal of the tumor. Herein, the most explored localized delivery systems for the treatment of CC, namely, nanofibers, nanoparticles, in situ gel, liposome, and hydrogel, have been discussed in detail. These carriers have exceptional properties that have been further modified with the aid of a wide range of polymers in order to serve the required purpose of therapeutic effect, safety, and stability. Further, the safety of these delivery systems toward vital organs has also been discussed.


Asunto(s)
Antineoplásicos , Nanopartículas , Neoplasias del Cuello Uterino , Femenino , Recién Nacido , Humanos , Neoplasias del Cuello Uterino/tratamiento farmacológico , Sistemas de Liberación de Medicamentos , Liposomas , Hidrogeles
3.
J Ethnopharmacol ; 328: 117991, 2024 Jun 28.
Artículo en Inglés | MEDLINE | ID: mdl-38460574

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Glinus oppositifolius (L.) Aug. DC. belongs to the family Molluginaceae, an annual prostrate herb traditionally used to treat inflammations, arthritis, malarial, wounds, fevers, diarrhoea, cancer, stomach discomfort, jaundice, and intestinal parasites. However, the anti-arthritic activity of the aerial part has still not been reported. AIM OF THE STUDY: To investigate the antioxidant and anti-arthritic activity of G. oppositifolius in Complete Freund's Adjuvant (CFA) induced rats. MATERIALS AND METHODS: The dried aerial parts of this plant material were defatted with n-hexane and extracted by methanol using a soxhlet apparatus. The in vitro anti-arthritic activity of methanolic extract of G. oppositifolius (MEGO) was evaluated in protein denaturation, membrane stabilization, and inhibition of proteinase assay at 25, 50, 100, 200, and 400 µg/ml concentrations. Female Wistar rats were immunized sub-dermally into the right hind paw with 0.1 ml of CFA. Rats were administered with MEGO at doses of 200 and 400 mg/kg once daily for fourteen days after arthritis induction. Assessment of arthritis was performed by measuring paw diameter, arthritic index, arthritic score, body weight, organ weight, and hematological and biochemical parameters, followed by the analysis of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), interleukin-1-beta (IL-1ß), cyclooxygenase-2 (COX-2), interleukin 13 (IL-13) and interleukin 10 (IL-10) and histopathological study. In vivo antioxidant effect was investigated in enzymatic assays. The presence of phytoconstituents was analyzed by Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Mass Spectrometry (LC-MS), respectively. In silico molecular docking study of the compounds was carried out against COX-2, IL-1ß, IL-6, and TNF-α using AutoDock 4.2 and BIOVIA-Discovery Studio Visualizer software. RESULTS: MEGO's in vitro anti-arthritic activity showed dose-dependent inhibition of protein denaturation, membrane stabilization, and proteinase inhibition, followed by significant in vivo anti-arthritic activity. The rats treated with MEGO showed tremendous potential in managing arthritis-like symptoms by restoring hematological, biochemical, and histological changes in CFA-induced rats. MEGO (200 and 400 mg/kg) showed a significant alleviation in the levels of hyper expressed inflammatory mediators (TNF-α, IL-1ß, and IL-6) and oxidative stress (SOD, CAT, GSH, and LPO) in CFA-induced rats. Spergulagenin-A as identified by LC-MS analysis, exhibited the highest binding affinity against COX-2 (-8.6), IL-1ß (7.2 kcal/mol), IL-6 (-7.4 kcal/mol), and TNF-α (-6.5 kcal/mol). CONCLUSIONS: Provided with the comprehensive investigation, methanolic extract of G. oppositifolius against arthritic-like condition is a proof of concept that revalidates its ethnic claim. The presence of Spergulagenin-A might be responsible for the anti-arthritic activity.


Asunto(s)
Artritis Experimental , Molluginaceae , Ratas , Animales , Factor de Necrosis Tumoral alfa , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Interleucina-6 , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Ratas Wistar , Ciclooxigenasa 2 , Simulación del Acoplamiento Molecular , Quimiometría , Artritis Experimental/inducido químicamente , Artritis Experimental/tratamiento farmacológico , Metanol/química , Antioxidantes/uso terapéutico , Interleucina-13 , Péptido Hidrolasas , Componentes Aéreos de las Plantas
4.
AAPS PharmSciTech ; 25(2): 31, 2024 Feb 07.
Artículo en Inglés | MEDLINE | ID: mdl-38326518

RESUMEN

Drug delivery to the buccal mucosa is one of the most convenient ways to treat common mouth problems. Here, we propose a spray-dried re-dispersible mucoadhesive controlled release gargle formulation to improve the efficacy of chlorhexidine. The present investigation portrays an approach to get stable and free-flowing spray-dried porous aggregates of chlorhexidine-loaded sodium alginate nanoparticles. The ionic gelation technique aided with the chlorhexidine's positive surface charge-based crosslinking, followed by spray drying of the nanoparticle's dispersion in the presence of lactose- and leucine-yielded nano-aggregates with good flow properties and with a size range of about 120-350 nm. Provided with the high entrapment efficiency (87%), the particles showed sustained drug release behaviors over a duration of 10 h, where 87% of the released drug got permeated within 12 h. The antimicrobial activity of the prepared formulation was tested on S. aureus, provided with a higher zone of growth inhibition than the marketed formulation. Aided with an appropriate mucoadhesive strength, this product exhibited extended retention of nanoparticles in the throat region, as shown by in vivo imaging results. In conclusion, the technology, provided with high drug retention and extended effect, could be a potential candidate for treating several types of throat infections.


Asunto(s)
Clorhexidina , Faringe , Staphylococcus aureus , Sistemas de Liberación de Medicamentos/métodos , Preparaciones de Acción Retardada , Antisépticos Bucales , Tamaño de la Partícula
5.
Pharm Nanotechnol ; 2024 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-38173065

RESUMEN

BACKGROUND: Dutasteride is approximately three times more potent than finasteride in treating alopecia. For reducing systemic exposure to dihydrotestosterone (DHT), researchers have shown special interest in developing topical formulations for treating androgenic alopecia. Dutasteride emulsification may lead to good skin penetration and improved availability in different lipophilic skin environments. OBJECTIVES: This study aimed to encapsulate the drug into the lipidic carrier system for better local availability in the scalp skin, develop and evaluate nanoemulgel of dutasteride to ensure efficient topical administration, and perform the in-vivo activity of the developed gel for improved efficacy against alopecia. METHODS: Dutasteride-loaded nanoemulsion was prepared by a high-speed homogenizer, followed by thickening of the dispersion using Carbopol 934. Skin permeation and accumulation were investigated in the excised skin of male Swiss albino mice. The nanoemulgel was characterized based on pH, stress stability, viscosity, and hardness. RESULTS: The optimized dutasteride-loaded nanoemulsion had a size of 252.33 ± 8.59 nm, PDI of 0.205 ± 0.60, and drug content of 98.65 ± 1.78%. Stress stability was performed was well observed in nanoemulsion formulation. Nanoemulgel evaluation results were as follows: pH 5-6 was desirable for topical application, hardness was 43 gm, and spreadability was 79 gm with in vitro release of nanoemulgel at 91.98% and permeation study at 13.67%. CONCLUSION: The in vivo studies demonstrated the growth of newer hair follicles and increased hair diameter and length in dutasteride-loaded nanoemulgel-treated alopecia animals compared to the marketed sample and testosterone-treated group. Provided with the same and long-term storage stability, the developed formulation is supposed to offer a good option for the topical administration of dutasteride in treating androgenic alopecia.

6.
Microb Pathog ; 186: 106494, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-38065294

RESUMEN

Bacterial vaginosis (BV) is a recurring, chronic infection that is difficult to treat due to the limited bioavailability of antimicrobials within vaginal epithelial cells. Vaginal administration, because of lower dosing and systemic exposure offers a viable option for treating vaginal infections. In this study, Metronidazole-loaded chitosan nanoparticles were synthesised employing borax (BX) or tannic acid (TA) as an antimicrobial crosslinking agent for treating BV. The prepared NPs were characterized for various physical, physicochemical, pharmaceutical, thermal and antibacterial properties. Morphological investigation revealed that nanoparticles prepared from 0.5 % w/v chitosan, 1.2 % w/v BX, and 0.4 % w/v metronidazole (MTZ) were non-spherical, with particle sizes of 377.4 ± 37.3 nm and a zeta potential of 34 ± 2.1 mV. The optimised formulation has MIC values of 24 ± 0.5 and 59 ± 0.5 µg/mL, against Escherichia coli (E.coli) and Candida albicans (C.albicans) respectively. The results of DSC and XRD demonstrated no change in the physical state of the drug in the finished formulation. Under simulated vaginal fluid, the optimised formulation demonstrates a cumulative drug release of about 90 % within 6h. The prepared borax crosslinked NPs exhibit anti-fungal activities by inhibiting ergosterol synthesis. The in-vivo antibacterial data indicated a comparable reduction in bacterial count compared to the marketed formulation in female Swiss albino mice treated with optimised nanoparticles. According to histopathological findings, the prepared nanoparticle was safe for vaginal use. Based on the experimental findings, it was concluded that MBCSNPs, due to their good physiochemical and antimicrobial properties, could serve as a potential topical alternative for treating BV and reducing fungal infection.


Asunto(s)
Quitosano , Nanopartículas , Vaginosis Bacteriana , Femenino , Humanos , Animales , Ratones , Metronidazol/farmacología , Vaginosis Bacteriana/tratamiento farmacológico , Quitosano/química , Portadores de Fármacos/química , Antibacterianos/química , Nanopartículas/química , Tamaño de la Partícula
7.
Int J Biol Macromol ; 255: 128212, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-37989434

RESUMEN

Bacterial vaginosis (BV) is a recurring infection that is difficult to treat due to the limited bioavailability of antimicrobials. In this study, Metronidazole (MTZ)-loaded chitosan nanoparticles (MCSNP) were synthesized employing phytic acid (PA) as a crosslinking agent for treating bacterial vaginosis. The prepared MCSNPs were characterized for size, shape, surface charge, compatibility, cytotoxicity, biofilm inhibition, and in-vitro/in-vivo antimicrobial activities. Morphological examination revealed that nanoparticles generated from 0.535 % w/v chitosan and 0.112 % w/v PA were non-spherical, discontinuous, and irregular, with zeta potential ranging from 25.00 ± 0.45 to 39 ± 0.7. The results of DSC and XRD demonstrated no change in the physical state of the drug in the finished formulation. The optimized formulation demonstrates a cumulative drug release of about 98 ± 1.5 % within 8 h. Antimicrobial studies demonstrated that the optimized formulation had enhanced efficacy against acid-adapted BV pathogens, with a MIC value of 0.9 ± 0.1 µg/mL. Compared to the MTZ alone, the in-vivo antibacterial results of in the case of developed nanoparticles showed a four-fold reduction in bacterial count in female Swiss albino mice. Based on the experimental findings, it was concluded that MCSNPs, due to their excellent physiochemical and antibacterial properties, could serve as a potential topical alternative for treating BV.


Asunto(s)
Quitosano , Nanopartículas , Vaginosis Bacteriana , Animales , Femenino , Ratones , Antibacterianos/química , Quitosano/química , Portadores de Fármacos/química , Metronidazol/farmacología , Nanopartículas/química , Ácido Fítico , Polielectrolitos , Vaginosis Bacteriana/tratamiento farmacológico
8.
AAPS PharmSciTech ; 24(7): 196, 2023 Oct 02.
Artículo en Inglés | MEDLINE | ID: mdl-37783948

RESUMEN

Despite having a wide range of therapeutic advantages, glycyrrhizin (GL) has few commercial applications due to its poor aqueous solubility. In this study, we combined the benefits of hydroxypropyl ß-cyclodextrin (HP-ßCD) supramolecular inclusion complexes and electrospun nanofibers to improve the solubility and therapeutic potential of GL. A molecular inclusion complex containing GL and HP-ßCD was prepared by lyophilization at a 1:2 molar ratio. GL and hydroxypropyl ß-cyclodextrin inclusion complexes were also incorporated into hyaluronic acid (HA) nanofibers. Prepared NF was analyzed for physical, chemical, thermal, and pharmaceutical properties. Additionally, a rat model of carrageenan-induced hind paw edema and macrophage cell lines was used to evaluate the anti-inflammatory activity of GL-HP-ßCD NF. The DSC and XRD analyses clearly showed the amorphous state of GL in nanofibers. In comparison to pure GL, GL-HP-ßCD NF displayed improved release (46.6 ± 2.16% in 5 min) and dissolution profiles (water dissolvability ≤ 6 s). Phase solubility results showed a four-fold increase in GL solubility in GL-HP-ßCD NF. In vitro experiments on cell lines showed that inflammatory markers like IL-1ß, TNF-α, and IL-6 were significantly lower in GL-HP-ßCD NF compared to pure GL (p < 0.01 and p < 0.05). According to in vivo results, the prepared nanofiber exhibits a better anti-inflammatory effect than pure GL (63.4% inhibition vs 53.7% inhibition). The findings presented here suggested that GL-HP-ßCD NF could serve as a useful strategy for improving the therapeutic effects of GL.


Asunto(s)
Ácido Glicirrínico , Nanofibras , Ratas , Animales , 2-Hidroxipropil-beta-Ciclodextrina/química , Solubilidad , Ácido Glicirrínico/farmacología , Nanofibras/química , Antiinflamatorios/farmacología
9.
RSC Adv ; 13(34): 23386-23395, 2023 Aug 04.
Artículo en Inglés | MEDLINE | ID: mdl-37546226

RESUMEN

Tm3+; Yb3+:Zn2TiO4 samples have been synthesized using a solid state reaction route. The phase, lattice parameters, crystallite size has been examined using X-ray Diffraction (XRD) and high resolution transmission electron microscopy (HRTEM). An intense peak of Yb3+ codoped samples is observed near ∼957 nm due to the 2F7/2 → 2F5/2 transition in diffuse reflectance spectra (DRS), which confirms the presence of Yb3+ ion in the prepared compound. The optical band gap of Yb3+ codoped samples has been calculated using Kubelka-Munk function. The Raman spectra corresponds to incorporation of Tm3+/Yb3+ at the octahedral and tetrahedral site of the spinel host. The emission spectra recorded by using 370 nm excitation wavelength shows intense blue colour band corresponding to the 1G4 → 3H6 transition of Tm3+ ion. The upconversion (UC) emission spectra recorded by using 980 nm laser excitation source shows emission bands due to the 1G4 → 3H6, 1G4 → 3F4 and 3H4 → 3H6 transitions of Tm3+ ion in the host matrix lying in the blue, red and NIR regions respectively. There is effective enhancement of about ∼35 times in the blue UC emission intensity with incorporation of Yb3+ at 3% doping concentration in the prepared sample. The anti-counterfeit application of the optimized upconverting phosphor has been successfully demonstrated.

10.
RSC Adv ; 13(29): 20342-20350, 2023 Jun 29.
Artículo en Inglés | MEDLINE | ID: mdl-37425634

RESUMEN

The developed SnWO4 phosphors incorporated with Ho3+, Yb3+ and Mn4+ ions have been explored under 980 nm laser irradiation. The molar concentration of dopants has been optimized to 0.5 Ho3+, 3.0 Yb3+ and 5.0 Mn4+ in SnWO4 phosphors. The upconversion (UC) emission from the codoped SnWO4 phosphors has been substantially amplified up to 13 times and described based on the energy transfer and charge compensation. On incorporating the Mn4+ ions in the Ho3+/Yb3+ codoped system the sharp green luminescence shifted to reddish broadband emission due to the photon avalanche mechanism. The processes accountable for the concentration quenching have been described based on critical distance. The interaction responsible for the concentration quenching in Yb3+ sensitized Ho3+ and Ho3+/Mn4+:SnWO4 phosphors is considered to be dipole-quadrupole and exchange interaction type, respectively. The activation energy 0.19 eV has been determined, and the phenomenon of thermal quenching is discussed using a configuration coordinate diagram.

11.
RSC Adv ; 13(30): 21096-21104, 2023 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-37448640

RESUMEN

This study employed solid-state synthesis to develop the green emitting Er3+-Yb3+:NaZr2(PO4)3, NASICON material. Using Rietveld refinement, the crystallographic variables of the synthesized phosphors were precisely calculated. The upconverting phenomenon was seen with naked eye when exposed to 980 nm laser radiation. The intermediate excited state dependency on the unusual photon number dependence on the green and red emission has been understood using the steady-state rate law equations. Further, the temperature sensing performances with good repeatability were compared with different laser densities, and it was found that the prepared phosphors could be an ideal material for upconverting and temperature sensing applications.

12.
Mikrochim Acta ; 190(8): 301, 2023 07 18.
Artículo en Inglés | MEDLINE | ID: mdl-37464230

RESUMEN

Microneedle (MN) technology plays a significant role in bioengineering as it allows for minimally invasive exposure to the skin via the non-invasive procedure, increased drug permeability, and improved biological molecule detectability in the epidermal layers, all while improving therapeutic safety and effectiveness. However, MNs have several significant drawbacks, including difficulty scaling up, variability in drug delivery pattern regarding the skin's external environment, blockage of dermal tissues, induction of inflammatory response at the administration site, and limitation of dosing based on the molecular weight of drug and size. Despite these drawbacks, MNs have emerged as a special transdermal theranostics instrument in clinical research to assess physiological parameters. Bioimaging technology relies on microneedles that can measure particular analytes in the extracellular fluid effectively by crossing the stratum corneum, making them "a unique tool in diagnostics detection and therapeutic application inside the body." This review article discusses the recent advances in the applications especially related to the diagnostics and toxicity challenges of microneedles. In addition, this review article discusses the clinical state and commercial accessibility of microneedle technology-based devices in order to provide new information to scientists and researchers.


Asunto(s)
Expediciones , Piel , Administración Cutánea , Preparaciones Farmacéuticas , Epidermis
13.
RSC Adv ; 13(23): 15833-15842, 2023 May 22.
Artículo en Inglés | MEDLINE | ID: mdl-37250230

RESUMEN

The Er3+/Yb3+:NaGd(WO4)2 phosphors and the phosphor-in-glass (PIG) have been synthesized employing a typical approach to investigate their structural, morphological and optical properties. Several PIG samples containing different amounts of NaGd(WO4)2 phosphor have been manufactured by sintering the phosphor and glass [TeO2-WO3-ZnO-TiO2] frit together at 550 °C, and its impact on the luminescence characteristics has been extensively studied. It has been noticed that the upconversion (UC) emission spectra of PIG under 980 nm excitation display similar characteristic emission peaks to the phosphors. The maximum absolute sensitivity of the phosphor and PIG is 17.3 × 10-3 K-1 @ 473 K and the maximum value of relative sensitivity is 10.0 × 10-3 K-1 @ 296 K and 10.7 × 10-3 K-1 @ 298 K, respectively. However, thermal resolution at room temperature has been improved in the case of PIG as compared to the NaGd(WO4)2 phosphor. As compared to the Er3+/Yb3+ codoped phosphor and glass, the less thermal quenching of luminescence has been observed in PIG.

14.
Curr Pharm Des ; 2023 May 26.
Artículo en Inglés | MEDLINE | ID: mdl-37246329

RESUMEN

BACKGROUND: Viral disease is a well-known cause of a significant impact on economic losses and threatens developed and developing societies. High mutation rates and the lack of ability of conventional formulations to target specific cells pose substantial hurdles to the successful treatment of viral diseases.

Methods: We conducted a preliminary search by a standard procedure. With hand searching, we conducted an advanced search across several electronic databases. After defining the selection criteria, two writers independently reviewed and evaluated the first 500 abstracts before screening the remaining 300. Since there was 97% agreement on the screening decisions, only one reviewer conducted the screening. The pre-planned data extraction process was accomplished, and the thoroughness of the description of participation techniques was assessed. Additional data extraction was carried out for articles with the most detailed illustrations. Four stakeholder representatives co-authored this systematic review.

Results: Incorporating selective carbohydrate polymers into the antiviral pharmaceutical compositions could help to manage biological complications associated with viral infections. We included 172 papers in which authors were involved in a systematic review. The present review explains the role of carbohydrate polymers (chitosan, carrageenan, alginate, cyclodextrin, dextran, and heparin) in the prevention and treatment of viral infections in terms of their source, molecular weight, surface charge, chemical composition, and structure. Additionally, the review describes the primary mechanism of drug delivery performance of carbohydrate polymers to improve the antiviral properties and pharmacokinetic behaviour of lamivudine, zidovudine, acyclovir, etc.

Conclusion: The article discussed the role of carbohydrate polymers in mitigating virus-induced associated complications like bacterial infection, cardiovascular disorder, oxidative stress, and metabolic disorder. As a result, this work will provide valuable information to scientists, researchers, and clinicians for suitable carbohydrate polymer-based pharmaceutical development.

15.
J Drug Target ; 31(4): 354-368, 2023 04.
Artículo en Inglés | MEDLINE | ID: mdl-36604804

RESUMEN

Malaria is a life-threatening parasitic disease transmitted by the infected female Anopheles mosquito. The development of drug tolerance and challenges related to the drugs' pharmacodynamic and pharmacokinetic parameters limits the antimalarial therapeutics response. Currently, nanotechnology-based drug delivery system provides an integrative platform for antimalarial therapy by improving the drug physicochemical properties, combating multidrug resistance, and lowering antimalarial drug-related toxicity. In addition, surface engineered nanocarrier systems offer a variety of alternatives for site-specific/targeted delivery of antimalarial therapeutics, anticipating better clinical outcomes at low drug concentrations and low toxicity profiles, as well as reducing the likelihood of the emergence of drug resistance. So, constructing nano carrier-based approaches for drug delivery has been considered the foremost strategy to combat malaria. This review focuses on the numerous nanotherapeutic strategies utilised to treat malaria as well as the benefits of nanotechnology as a potentially effective therapeutic.


Asunto(s)
Antimaláricos , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Malaria , Animales , Femenino , Humanos , Antimaláricos/farmacología , Antimaláricos/uso terapéutico , Nanomedicina , Malaria/tratamiento farmacológico , Sistemas de Liberación de Medicamentos , Resistencia a Medicamentos
16.
Pharm Dev Technol ; 28(1): 78-94, 2023 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-36564887

RESUMEN

Oral mucositis is a serious issue in patients receiving oncological therapies. Mucosal protectants considered to be one of the preferred choices used in the management of mucositis. However, the protective efficacy of currently available mucosal protectants has been significantly compromised due to poor retention, lack of lubrication, poor biodegradability, and inability to manage secondary complications. Chitosan is a promising material for mucosal applications due to its beneficial biomedical properties. Chitosan is also anti-inflammatory, anti-microbial, and capable of scavenging free radicals, makes it a good candidate for the treatment of oral mucositis. Additionally, chitosan's amino polysaccharide skeleton permits a number of chemical alterations with better bioactive performance. This article provides a summary of key biological properties of chitosan and its derivatives that are useful for treating oral mucositis. Current literature evidence shows that Chitosan has superior mucosal protective properties when utilised alone or as delivery systems for co-encapsulated drugs.


Asunto(s)
Quitosano , Neoplasias , Estomatitis , Humanos , Quitosano/química , Materiales Biocompatibles , Estomatitis/tratamiento farmacológico , Estomatitis/etiología , Neoplasias/tratamiento farmacológico
17.
J Biomol Struct Dyn ; 41(17): 8093-8108, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36214696

RESUMEN

Psoriasis is a chronic autoimmune pathological condition characterized by hyperactivation of proinflammatory cytokines (IL-6, TNF-α, IL-17, IL-23, etc.). Severe drug-associated toxicities like hepatotoxicity and nephrotoxicity (Methotrexate), teratogenicity (Tazarotene), hypercholesterolemia (Cyclosporine) and hypercalcemia (tacalcitol), are the forefront challenges that demand an alternative approach for the treatment of psoriasis. In the present study, a natural lead molecule 'Betulin' (BE, lup-20(29)-ene-3b,28-diol) was isolated from Betula utilis and subsequently, structure-based molecular docking was employed to identify the molecular target for psoriasis. The computational analysis reflects better affinity of BE towards pro-inflammatory cytokine as compared to standard drugs. Apart from this BE shows a greater affinity towards the overexpressed Glut-1 receptor in comparison to standard drug Metformin (Met). Based on the in silico screening the isolated lead compound was further processed for the evaluation of anti-psoriatic activity via imiquimod (IMQ 5%) induced psoriasis-like skin inflammation model. In vivo screening models were characterized by different parameters (psoriasis area and severity index (PASI) scores, macroscopically and behavioral evaluation, splenomegaly, cytokine levels and histological changes) and compared among the experimental groups. The experimental finding reflects comparable results of PASI score, i.e., 57.14% and 61.9% recovery of test BE-solution (180 mg/kg) and standard Betamethasone di-propionate ointment (BD-oint.0.5 mg/g), respectively. Focusing on other parameters, BE shows relative results such as an enhanced macroscopically with behavioral conditions, reducing the expression of proinflammatory cytokine as well as restoring histological changes with that of BD. These findings suggest that BE-isolated phytoconstituents from Betula utilis could be a potential agent and a step closer to psoriasis treatment. HIGHLIGHTPsoriasis is a multifaceted, immunologically mediated disease consequences production of high levels of proinflammatory mediators and overexpression of Glut-1 transporters that trigger keratinocyte proliferation and inflammatory cascades.A Himalayan silver birch, Betula utilis (Bhojpatra) contains many steroidal terpenes which are responsible for various pharmacological activities that could be exploited in drug development in psoriasis.The computational analysis of BE reflects a better affinity toward the proinflammatory cytokines with their target receptors and indicates a satisfactory range with a slight deviation from Jorgensen and Lipinski's rule and possesses a significant drug choice for psoriasis.Preclinical findings of BE-solution (BE-sol) give a positive response towards IMQ-induced psoriasis-like skin inflammation model.[Figure: see text]Communicated by Ramaswamy H. Sarma.

18.
Curr Drug Deliv ; 20(7): 904-918, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-35838220

RESUMEN

Cancer is the world's fifth-most significant cause of related death and the second most commonly diagnosed malignancy among women and men. Some of its types, like brain cancer, colon cancer, and breast cancer, are threatened and considered fatal. These cancers are more prevalent in developed and underdeveloped countries. Still, doxorubicin is considered a gold standard drug and the only molecule used in multiple types of cancer. However, the toxicity and biopharmaceutical hindrances like poor solubility, poor permeability, and high in vivo fate of drug cause low systematic circulation. The creation of a multifunctional nanocarrier for targeted medication delivery that can transport and accumulate drugs at cancer sites should help to lessen the likelihood of side effects. These nanocarriers improve the targetability of infected tissue and the therapeutic circulation of drugs. Hence, the present review focused on the improved targetability of doxorubicin using different nanocarriers and its possible outcomes in different types of cancer. Moreover, the prior art also discussed various challenges and prospects of improved doxorubicin delivery and its therapeutic outcomes.


Asunto(s)
Antineoplásicos , Neoplasias de la Mama , Femenino , Humanos , Doxorrubicina , Neoplasias de la Mama/tratamiento farmacológico , Sistemas de Liberación de Medicamentos , Portadores de Fármacos/uso terapéutico , Antineoplásicos/uso terapéutico
19.
J Biomater Sci Polym Ed ; 34(7): 986-1017, 2023 05.
Artículo en Inglés | MEDLINE | ID: mdl-36541167

RESUMEN

Microneedle arrays are micron-sized needles usually attached to a supporting base or patch facilitated drug delivery for systemic effects. Polyvinylpyrrolidone (PVP) is a lactam polymer containing an internal amide linkage. Because of its versatility and biocompatibility, it has been widely utilized to treat several skin, bone and eye problems. Due to its specific and unique properties, the researchers realize its utility as a polymer of tremendous potential. PVP-based dissolvable microneedles have widely been utilized as a carrier for delivering DNAs, proteins, vitamins, and several biological macromolecules transdermally. However, it does not get biodegraded into the body. Therefore, the presence of its fragments in the body post-treatment needs proper justification. The adequate justification for the fate of the fragment's end products in the body will allow even better utilization of PVP. This review analyses and illustrates various experimental findings to highlight the most recent advancements and applications of PVP microneedles in drug delivery systems and cosmetology and the potential for PVP microneedles in treating dermal and systemic disorders. This review presents the expected mode of PVP biodegradation in aqueous and soil environments as a waste material, its inertness, biocompatibility, and the importance of PVP as a fabricating material, pharmaceutical uses, and non-toxic profile.


Asunto(s)
Povidona , Piel , Microinyecciones , Polímeros/metabolismo , Sistemas de Liberación de Medicamentos , Administración Cutánea
20.
Plants (Basel) ; 11(17)2022 Aug 25.
Artículo en Inglés | MEDLINE | ID: mdl-36079585

RESUMEN

Plants interact with diverse microbial communities and share complex relationships with each other. The intimate association between microbes and their host mutually benefit each other and provide stability against various biotic and abiotic stresses to plants. Endophytes are heterogeneous groups of microbes that live inside the host tissue without showing any apparent sign of infection. However, their functional attributes such as nutrient acquisition, phytohormone modulation, synthesis of bioactive compounds, and antioxidant enzymes of endophytes are similar to the other rhizospheric microorganisms. Nevertheless, their higher colonization efficacy and stability against abiotic stress make them superior to other microorganisms. In recent studies, the potential role of endophytes in bioprospecting has been broadly reported. However, the molecular aspect of host-endophyte interactions is still unclear. In this study, we have briefly discussed the endophyte biology, colonization efficacy and diversity pattern of endophytes. In addition, it also summarizes the molecular aspect of plant-endophyte interaction in biotic stress management.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...